NEOM has signed a strategic Memorandum of Understanding (MoU) with WuXi AppTec, a global leader in contract research, development, and manufacturing services for the pharmaceutical industry.
Under this agreement, both parties will collaborate to explore opportunities for localizing pharmaceutical research, development, and manufacturing within the Kingdom of Saudi Arabia. In the long term, the partnership aims to establish a world-class contract development and manufacturing facility in OXAGON—NEOM’s hub for clean and advanced industries—or at other strategic sites across the country.
Aligned with Saudi Arabia’s goals for economic diversification and innovation, this MoU marks a major milestone in advancing the Kingdom’s biotechnology ambitions. It underscores a shared commitment to fostering sustainable growth and building a resilient pharmaceutical and healthcare ecosystem.
The collaboration represents the fusion of WuXi AppTec’s global expertise with NEOM’s visionary leadership in developing a next-generation biopharmaceutical manufacturing landscape. It is a pivotal step toward creating a fully integrated industrial environment that serves both regional and global markets, leveraging OXAGON’s clean-industry infrastructure and WuXi AppTec’s cutting-edge pharmaceutical capabilities.
This agreement reflects the strategic alignment between two pioneering organizations: WuXi AppTec, with its extensive experience in biopharmaceutical innovation, and NEOM, serving as a key enabler of Saudi Arabia’s National Biotechnology Strategy under Vision 2030.
Finally, through this collaboration, both partners aim to open new pathways for innovation, contribute to the Kingdom’s long-term development goals, and set a new global standard for partnership in pharmaceutical advancement.
Related Topics:
Estidamah Teams up with NEOM Boosting Greenhouse Operations
SAWANI, Tarshid Sign Agreement for Solar Energy Project
Estidamah, Saudi Coffee Company Collaborate to Elevate Saudi Arabia’s Coffee Industry
